Evommune EVMN
NYSE EVMN
$8.64 +0.80 (+10.14%)
As of: Nov 11, 2026 · 3:59 PM EST

Evommune (EVMN) Operating Expenses (2024 - 2026)

Updated

Analysis

Evommune (EVMN) Operating Expenses (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 15.99 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 11.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 11.14 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 12.53 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.00 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 6.66 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 4.84 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 7.09 Bn
10 Evommune 285.17 Mn -352.34 Mn - 34.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.90 Mn
Mar 31, 2026 23.95 Mn
Dec 31, 2025 29.72 Mn
Sep 30, 2025 23.33 Mn
Jun 30, 2025 22.99 Mn
Mar 31, 2025 18.03 Mn
Dec 31, 2024 21.45 Mn
Sep 30, 2024 16.52 Mn
API Access

Evommune Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=EVMN&period=max&api_key=YOUR_API_KEY